Literature DB >> 20719985

Monofunctional and polyfunctional CD8+ T cell responses to human herpesvirus 8 lytic and latency proteins.

Lauren Lepone1, Giovanna Rappocciolo, Emilee Knowlton, Mariel Jais, Paolo Piazza, Frank J Jenkins, Charles R Rinaldo.   

Abstract

Human herpesvirus 8 (HHV-8) is the etiological agent of Kaposi's sarcoma, primary effusion lymphoma, and multicentric Castleman's disease. It is postulated that CD8(+) T cell responses play an important role in controlling HHV-8 infection and preventing development of disease. In this study, we investigated monofunctional and polyfunctional CD8(+) T cell responses to HHV-8 lytic proteins gB (glycoprotein B) and K8.1 and latency proteins LANA-1 (latency-associated nuclear antigen-1) and K12. On the basis of our previous findings that dendritic cells (DC) reveal major histocompatibility complex (MHC) class I epitopes in gB, we used a DC-based system to identify 2 novel epitopes in gB, 2 in K8.1, 5 in LANA-1, and 1 in K12. These new HHV-8 epitopes activated monofunctional and polyfunctional CD8(+) T cells that produced various combinations of gamma interferon, interleukin 2, tumor necrosis factor alpha, macrophage inhibitory protein 1β, and cytotoxic degranulation marker CD107a in healthy HHV-8-seropositive individuals. We were also able to detect HHV-8-specific CD8(+) T cells in peripheral blood samples using HLA A*0201 pentamer complexes for one gB epitope, one K8.1 epitope, two LANA-1 epitopes, and one K12 epitope. These immunogenic regions of viral lytic and latency proteins could be important in T cell control of HHV-8 infection.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20719985      PMCID: PMC2952991          DOI: 10.1128/CVI.00189-10

Source DB:  PubMed          Journal:  Clin Vaccine Immunol        ISSN: 1556-679X


  45 in total

1.  Short- and long-term effects of highly active antiretroviral therapy on Kaposi sarcoma-associated herpesvirus immune responses and viraemia.

Authors:  Dimitra Bourboulia; Diana Aldam; Dimitrios Lagos; Elizabeth Allen; Ian Williams; David Cornforth; Andrew Copas; Chris Boshoff
Journal:  AIDS       Date:  2004-02-20       Impact factor: 4.177

2.  Identification of CD8+ T cell epitopes within lytic antigens of human herpes virus 8.

Authors:  Eliana Ribechini; Cinzia Fortini; Mauro Marastoni; Serena Traniello; Susanna Spisani; Paolo Monini; Riccardo Gavioli
Journal:  J Immunol       Date:  2006-01-15       Impact factor: 5.422

3.  Motif inference reveals optimal CTL epitopes presented by HLA class I alleles highly prevalent in southern Africa.

Authors:  Isobella Honeyborne; Almas Rathod; Rico Buchli; Dhanwanthie Ramduth; Eshia Moodley; Prinisha Rathnavalu; Senica Chetty; Cheryl Day; Christian Brander; William Hildebrand; Bruce D Walker; Photini Kiepiela; Philip J R Goulder
Journal:  J Immunol       Date:  2006-04-15       Impact factor: 5.422

4.  Impact of HLA-B alleles, epitope binding affinity, functional avidity, and viral coinfection on the immunodominance of virus-specific CTL responses.

Authors:  Florian Bihl; Nicole Frahm; Loriana Di Giammarino; John Sidney; Mina John; Karina Yusim; Tonia Woodberry; Kaori Sango; Hannah S Hewitt; Leah Henry; Caitlyn H Linde; John V Chisholm; Tauheed M Zaman; Eunice Pae; Simon Mallal; Bruce D Walker; Alessandro Sette; Bette T Korber; David Heckerman; Christian Brander
Journal:  J Immunol       Date:  2006-04-01       Impact factor: 5.422

5.  Identification of Kaposi's sarcoma-associated herpesvirus (KSHV)-specific cytotoxic T-lymphocyte epitopes and evaluation of reconstitution of KSHV-specific responses in human immunodeficiency virus type 1-Infected patients receiving highly active antiretroviral therapy.

Authors:  John Wilkinson; Alethea Cope; Jas Gill; Dimitra Bourboulia; Peter Hayes; Nesrina Imami; Toru Kubo; Anne Marcelin; Vincent Calvez; Robin Weiss; Brian Gazzard; Chris Boshoff; Frances Gotch
Journal:  J Virol       Date:  2002-03       Impact factor: 5.103

6.  Kaposi sarcoma-associated herpesvirus (KSHV) seroprevalence in population-based samples of African children: evidence for at least 2 patterns of KSHV transmission.

Authors:  Lisa M Butler; Grant Dorsey; Wolfgang Hladik; Philip J Rosenthal; Christian Brander; Torsten B Neilands; Georgina Mbisa; Denise Whitby; Photini Kiepiela; Anisa Mosam; Similo Mzolo; Sheila C Dollard; Jeffrey N Martin
Journal:  J Infect Dis       Date:  2009-08-01       Impact factor: 5.226

7.  Estimation of human herpesvirus 8 prevalence in high-risk patients by analysis of humoral and cellular immunity.

Authors:  Brigitta M Lönard; Martina Sester; Urban Sester; Hans W Pees; Nikolaus Mueller-Lantzsch; Hans Köhler; Barbara C Gärtner
Journal:  Transplantation       Date:  2007-07-15       Impact factor: 4.939

8.  Kaposi's sarcoma-associated herpesvirus cytotoxic T lymphocytes recognize and target Darwinian positively selected autologous K1 epitopes.

Authors:  Justin Stebbing; Dimitra Bourboulia; Margaret Johnson; Stephen Henderson; Ian Williams; Natalie Wilder; Mervyn Tyrer; Mike Youle; Nesrina Imami; Toru Kobu; Wolfgang Kuon; Joachim Sieper; Frances Gotch; Chris Boshoff
Journal:  J Virol       Date:  2003-04       Impact factor: 5.103

Review 9.  CD8+ T cell immunity to Epstein-Barr virus and Kaposi's sarcoma-associated herpes virus.

Authors:  Andrew D Hislop; Shereen Sabbah
Journal:  Semin Cancer Biol       Date:  2008-11-01       Impact factor: 15.707

10.  CD8+ cytotoxic T lymphocyte responses to lytic proteins of human herpes virus 8 in human immunodeficiency virus type 1-infected and -uninfected individuals.

Authors:  Q J Wang; F J Jenkins; L P Jacobson; Y X Meng; P E Pellett; L A Kingsley; K G Kousoulas; A Baghian; C R Rinaldo
Journal:  J Infect Dis       Date:  2000-08-17       Impact factor: 5.226

View more
  19 in total

1.  Kaposi's Sarcoma-Associated Herpesvirus Latency-Associated Nuclear Antigen Inhibits Major Histocompatibility Complex Class II Expression by Disrupting Enhanceosome Assembly through Binding with the Regulatory Factor X Complex.

Authors:  Suhani Thakker; Pravinkumar Purushothaman; Namrata Gupta; Shanthan Challa; Qiliang Cai; Subhash C Verma
Journal:  J Virol       Date:  2015-03-04       Impact factor: 5.103

2.  Altered Peptide Ligands Impact the Diversity of Polyfunctional Phenotypes in T Cell Receptor Gene-Modified T Cells.

Authors:  Timothy T Spear; Yuan Wang; Thomas W Smith; Patricia E Simms; Elizabeth Garrett-Mayer; Lance M Hellman; Brian M Baker; Michael I Nishimura
Journal:  Mol Ther       Date:  2018-02-02       Impact factor: 11.454

3.  Regulatory T Cell Effect on CD8+ T Cell Responses to Human Herpesvirus 8 Infection and Development of Kaposi's Sarcoma.

Authors:  Lauren M Lepone; Giovanna Rappocciolo; Paolo A Piazza; Diana M Campbell; Frank J Jenkins; Charles R Rinaldo
Journal:  AIDS Res Hum Retroviruses       Date:  2017-03-02       Impact factor: 2.205

Review 4.  Adaptive immune responses to Kaposi's sarcoma-associated herpesvirus.

Authors:  Angela Nalwoga; Denise Whitby
Journal:  Curr Opin Immunol       Date:  2022-07-08       Impact factor: 7.268

5.  Kaposi's sarcoma-associated herpesvirus-encoded viral IRF3 modulates major histocompatibility complex class II (MHC-II) antigen presentation through MHC-II transactivator-dependent and -independent mechanisms: implications for oncogenesis.

Authors:  Jianmin Zuo; Andrew D Hislop; Carol S Leung; Shereen Sabbah; Martin Rowe
Journal:  J Virol       Date:  2013-02-28       Impact factor: 5.103

6.  Dendritic cells reveal a broad range of MHC class I epitopes for HIV-1 in persons with suppressed viral load on antiretroviral therapy.

Authors:  Xiao-Li Huang; Zheng Fan; LuAnn Borowski; Robbie B Mailliard; Morgane Rolland; James I Mullins; Richard D Day; Charles R Rinaldo
Journal:  PLoS One       Date:  2010-09-23       Impact factor: 3.240

Review 7.  Epidemiology and transmission of Kaposi's sarcoma-associated herpesvirus.

Authors:  Veenu Minhas; Charles Wood
Journal:  Viruses       Date:  2014-11-04       Impact factor: 5.048

8.  Professional antigen presenting cells in human herpesvirus 8 infection.

Authors:  Emilee R Knowlton; Lauren M Lepone; Jun Li; Giovanna Rappocciolo; Frank J Jenkins; Charles R Rinaldo
Journal:  Front Immunol       Date:  2013-01-21       Impact factor: 7.561

9.  The T-Cell Immune Response against Kaposi's Sarcoma-Associated Herpesvirus.

Authors:  Rebecca C Robey; Salvinia Mletzko; Frances M Gotch
Journal:  Adv Virol       Date:  2011-01-16

10.  Human Herpesvirus 8 Infects and Replicates in Langerhans Cells and Interstitial Dermal Dendritic Cells and Impairs Their Function.

Authors:  Giovanna Rappocciolo; Mariel Jais; Paolo A Piazza; Diana C DeLucia; Frank J Jenkins; Charles R Rinaldo
Journal:  J Virol       Date:  2017-09-27       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.